Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer-Reference-Cited by-同舟云学术

Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer

Published:2015-01-18 Issue:5 Volume:75 Page:539-549
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Roberts Matthew J.¹²³,Chow Clement W. K.¹,Schirra Horst Joachim³,Richards Renee¹,Buck Marion⁴,Selth Luke A.⁵,Doi Suhail A. R.⁶,Samaratunga Hema⁷,Perry-Keene Joanna⁸,Payton Diane⁸,Yaxley John²,Lavin Martin F.¹,Gardiner Robert A.¹²

Affiliation:

1. The University of Queensland; Centre for Clinical Research; Brisbane Qld Australia

2. Department of Urology; Royal Brisbane and Women's Hospital; Brisbane Qld Australia

3. The University of Queensland; Centre for Advanced Imaging; Brisbane Qld Australia

4. Department of Environmental Health Sciences; University Medical Centre Freiburg; Freiburg Germany

5. Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre; Freemasons Foundation Centre for Men's Health; The University of Adelaide; SA Australia

6. School of Population Health; The University of Queensland; Brisbane Qld Australia

7. Aquesta Pathology; Brisbane Qld Australia

8. Anatomical Pathology; Pathology Queensland; Brisbane Qld Australia

Funder

PCFA/Cancer Australia

PCFA

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.22942/fullpdf